CSF-1/CSF-1R and CCL2 (MCP-1)/CCR2 signaling in murine breast and pancreatic neuroendocrine cancers induces TAM recruitment and a pro-tumorigenic M2-like phenotype [28], [29]. This evidence concerns the gene CSF1 and pancreatic endocrine carcinoma.